Inovio Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Inovio Pharmaceuticals

10/05/2023 22:03

* Inovio Pharmaceuticals Inc  INO.OQ  reported a quarterly
adjusted loss of 16 cents​​ per share for the quarter ended in
March. The mean expectation of four analysts for the quarter was
for a loss of 14 cents per share.
    * Revenue fell 42.7% to $114.00 thousand from a year ago;
analysts
expected $275.00 thousand. 
    * Inovio Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 16 cents​.
    * The mean earnings estimate of analysts had risen by
about 14.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Inovio Pharmaceuticals Inc shares had risen by 2.1% this
quarter and lost 46.3% so far this year.
    * The company reported a quarterly loss of $40.65 million.
    * Wall Street's median 12-month price target for Inovio
Pharmaceuticals Inc is $1.20 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 09:03 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.14          -0.16          Missed
 Dec. 31 2022      -0.17          -0.21          Missed
 Sep. 30 2022      -0.30          -0.15          Beat
 Jun. 30 2022      -0.31          -0.46          Missed